Latest Breaking News On - Arrowhead pharmaceuticals - Page 10 : comparemela.com

Arrowhead Pharmaceuticals (ARWR) Set to Announce Earnings on Thursday

Arrowhead Pharmaceuticals (ARWR) Set to Announce Earnings on Thursday
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesHongbo luRoyal bankArrowhead pharmaceuticals company profileMorgan stanleyNews ratings for arrowhead pharmaceuticals dailyArrowhead pharmaceuticals stock downSecurities exchange commissionArrowhead pharmaceuticals incArrowhead pharmaceuticalsEarnings history for arrowhead pharmaceuticalsGet free reportPharmaceuticals stock downDirector victoria vakienerExchange commissionArrowhead pharmaceuticals daily

Jennifer Garner proud to show off her boyfriend – and you might recognize him

Jennifer Garner proud to show off her boyfriend – and you might recognize him
al-awassef.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from al-awassef.com Daily Mail and Mail on Sunday newspapers.

United statesJohn millerBen affleckJennifer lopezCaroline campbellJennifer garnerArrowhead pharmaceuticals

Amgen Reports Better-Than-Expected Q1 Results, $50M Milestone Payment - Amgen (NASDAQ:AMGN)

Amgen reported quarterly earnings of $3.96 per share which beat the analyst consensus estimate of $3.87 by 2.33%. The company said EPS decreased by 1% due to higher operating and interest expenses driven by the Horizon acquisition, partially offset by higher revenues.

Roberta bradwayRoyalty pharma plcAmgen incArrowhead pharmaceuticals incArrowhead pharmaceuticalsOutcomes trialRivian automotive receivesIncentive packageGoing on with rivianBenzinga pro

Daniel Gaudet, MD, PhD: Contextualizing Plozasiran Data from SHASTA-2, Upcoming MUIR Data

Daniel Gaudet, MD, PhD, discusses SHASTA-2 data and what cardiologists could learn from the forthcoming 48-week MUIR trial data from EAS 2024.

Daniel gaudetEli lillyBoehringer ingelheimAmerican college of cardiologyNovo nordiskArrowhead pharmaceuticalsAmerican collegeAnnual scientific sessionArrowhead pharmaceuticalNew amsterdam pharma

Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars

Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference based medicines that utilize the.

Christopher anzaloneExchange commissionArrowhead pharmaceuticalsArrowhead pharmaceuticals incSummer seriesSeries scheduleNervous systemHarbor statementPrivate securities litigation reform actAnnual reportQuarterly reports